Reaching More Patients with CGT: Screening, Genomics, Databases and Patient Diversity

19 Jan 2023
Clinical and Patient Considerations Track
Be The Match BioTherapies

3:30pm Chair Introduction

Gregory Fiore, Chief Executive Office, Exacis Therapeutics


3:35pm Presentation: Racial and Ethnic Diversity in Immuno-Oncology Clinical Trials

  • Review the current landscape of patient diversity in immuno-oncology trials leading to FDA approval
  • Discuss challenges and opportunities to increase patient diversity in oncology trials

Samik Upadhaya, Assistant Director of Scientific Affairs, Cancer Research Institute


3:50pm Presentation: Focusing on Donor Characteristics and Efficient Selection to Improve Allogeneic Cell Therapy Outcomes

  • How proven transplant infrastructure deliver cell and gene therapies
  • The complexity of HLA in cell selection
  • The use of machine learning in informing cell/source selection

Martin Maiers, Vice President, Research, Be The Match BioTherapies


4:05pm Presentation: TBA

Kevin Ramdas, Director, Medical Affairs and Clinical Operations, Longeveron


4:20pm Presentation: Clinical Trial Ecosystem in Cell Therapy and The Need for Patient Centric Trial Design and Execution

Tunç Toker, Chief Operating Officer, Galen Therapeutics


4:35pm Closing Panel with Q&A

With all session participants


Gregory Fiore
Founder and Chief Executive Officer
Exacis Biotherapeutics
Kevin Ramdas
Director, Clinical Operations
Martin Maiers
Vice President, Research
Be The Match BioTherapies
Samik Upadhaya
Assistant Director of Scientific Affairs
Cancer Research Institute
Tunç Toker
Chief Operating Officer
Galen Therapeutics